Published in Proc Natl Acad Sci U S A on January 31, 2003
Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol (2009) 2.99
Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A (2003) 2.37
Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br J Pharmacol (2009) 1.77
Peptide-guided gene delivery. AAPS J (2007) 1.57
Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? Int J Antimicrob Agents (2011) 1.28
Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates. J Control Release (2011) 1.09
Delivery of macromolecules into live cells by simple co-incubation with a peptide. Chembiochem (2010) 0.95
Enhanced membrane disruption and antibiotic action against pathogenic bacteria by designed histidine-rich peptides at acidic pH. Antimicrob Agents Chemother (2006) 0.92
Effective endogenous gene silencing mediated by pH responsive peptides proceeds via multiple pathways. J Control Release (2011) 0.92
Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy. Curr Pharm Des (2014) 0.88
Delivery of intracellular-acting biologics in pro-apoptotic therapies. Curr Pharm Des (2011) 0.87
Control of pH responsive peptide self-association during endocytosis is required for effective gene transfer. Biochim Biophys Acta (2011) 0.85
NMR structures of the histidine-rich peptide LAH4 in micellar environments: membrane insertion, pH-dependent mode of antimicrobial action, and DNA transfection. Biophys J (2010) 0.84
Vectofusin-1, a new viral entry enhancer, strongly promotes lentiviral transduction of human hematopoietic stem cells. Mol Ther Nucleic Acids (2013) 0.83
LAH4 enhances CD8+ T cell immunity of protein/peptide-based vaccines. Vaccine (2011) 0.83
Molecular Determinants of Vectofusin-1 and Its Derivatives for the Enhancement of Lentivirally Mediated Gene Transfer into Hematopoietic Stem/Progenitor Cells. J Biol Chem (2015) 0.83
Reversible liposome association induced by LAH4: a peptide with potent antimicrobial and nucleic acid transfection activities. Biophys J (2010) 0.80
Anthrax toxin-induced rupture of artificial lipid bilayer membranes. J Chem Phys (2013) 0.78
Buffering capacity and size of siRNA polyplexes influence cytokine levels. Mol Ther (2012) 0.78
Multifunctional spider silk polymers for gene delivery to human mesenchymal stem cells. J Biomed Mater Res B Appl Biomater (2014) 0.77
Lipid interactions of LAH4, a peptide with antimicrobial and nucleic acid transfection activities. Eur Biophys J (2014) 0.76
Functional peptides for siRNA delivery. Adv Drug Deliv Rev (2016) 0.75
Manipulating the pH response of 2,3-diaminopropionic acid rich peptides to mediate highly effective gene silencing with low-toxicity. J Control Release (2013) 0.75
pH-Dependent Membrane Interactions of the Histidine-Rich Cell-Penetrating Peptide LAH4-L1. Biophys J (2017) 0.75
Enhancement of lung gene delivery after aerosol: a new strategy using non-viral complexes with antibacterial properties. Biosci Rep (2017) 0.75
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A (1995) 18.16
Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev (1991) 7.12
Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell (1996) 6.84
The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem (1994) 2.84
Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci U S A (1999) 2.58
Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A (2002) 2.00
Activity of abundant antimicrobials of the human airway. Am J Respir Cell Mol Biol (1999) 1.93
Efficient gene transfer by histidylated polylysine/pDNA complexes. Bioconjug Chem (1999) 1.76
An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery. Hum Gene Ther (1998) 1.73
Polyethylenimine-mediated gene delivery: a mechanistic study. J Gene Med (2001) 1.66
Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry (1997) 1.56
Membrane helix orientation from linear dichroism of infrared attenuated total reflection spectra. Biophys J (1999) 1.52
Towards membrane protein design: pH-sensitive topology of histidine-containing polypeptides. J Mol Biol (1996) 1.46
A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. Gene Ther (1996) 1.31
New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. Mol Ther (2002) 1.22
Putative role of chloroquine in gene transfer into a human hepatoma cell line by DNA/lactosylated polylysine complexes. Exp Cell Res (1996) 1.15
The interactions of histidine-containing amphipathic helical peptide antibiotics with lipid bilayers. The effects of charges and pH. J Biol Chem (1999) 1.09
Calcitermin, a novel antimicrobial peptide isolated from human airway secretions. FEBS Lett (2001) 0.98
Efficient DNA transfection mediated by the C-terminal domain of human immunodeficiency virus type 1 viral protein R. J Virol (2000) 0.93
Peptide-based gene delivery. Curr Opin Mol Ther (1999) 0.88
Solid-state NMR investigations of interaction contributions that determine the alignment of helical polypeptides in biological membranes. FEBS Lett (2001) 0.86
Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors. Hum Gene Ther (2010) 3.37
Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science (2004) 2.71
Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy. Hum Mutat (2007) 1.89
CUG-BP1/CELF1 requires UGU-rich sequences for high-affinity binding. Biochem J (2006) 1.73
AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis. Hum Mol Genet (2008) 1.44
FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Invest (2004) 1.39
A 10 patient case report on the impact of plasmapheresis upon neutralizing factors against adeno-associated virus (AAV) types 1, 2, 6, and 8. Mol Ther (2011) 1.29
Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet A (2011) 1.26
Investigations of polypeptide rotational diffusion in aligned membranes by 2H and 15N solid-state NMR spectroscopy. J Am Chem Soc (2004) 1.19
Intracerebral administration of adeno-associated viral vector serotype rh.10 carrying human SGSH and SUMF1 cDNAs in children with mucopolysaccharidosis type IIIA disease: results of a phase I/II trial. Hum Gene Ther (2014) 1.19
Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice. Proc Natl Acad Sci U S A (2007) 1.17
Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector. Mol Ther (2005) 1.17
Phenotypic correction of alpha-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector. Mol Ther (2007) 1.13
Internal ribosome entry site structural motifs conserved among mammalian fibroblast growth factor 1 alternatively spliced mRNAs. Mol Cell Biol (2004) 1.09
Chromosomal context and epigenetic mechanisms control the efficacy of genome editing by rare-cutting designer endonucleases. Nucleic Acids Res (2012) 1.09
Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery. Pharm Res (2010) 1.08
Cationic amphipathic histidine-rich peptides for gene delivery. Biochim Biophys Acta (2006) 1.07
Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides. J Biol Chem (2008) 1.06
Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function. Proc Natl Acad Sci U S A (2005) 1.05
Evidence for a resident subset of cells with SP phenotype in the C2C12 myogenic line: a tool to explore muscle stem cell biology. Exp Cell Res (2004) 1.05
Transient immunomodulation allows repeated injections of AAV1 and correction of muscular dystrophy in multiple muscles. Mol Ther (2008) 1.04
Synthesis of linear polyethylenimine derivatives for DNA transfection. Bioconjug Chem (2003) 1.02
Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors. Hum Mol Genet (2003) 1.01
Structure and topology of the huntingtin 1-17 membrane anchor by a combined solution and solid-state NMR approach. Biophys J (2013) 1.01
SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa. Mol Ther (2010) 1.01
CD4+CD25+ regulatory T cells inhibit immune-mediated transgene rejection. Blood (2003) 1.01
Structure and dynamics of membrane-associated ICP47, a viral inhibitor of the MHC I antigen-processing machinery. J Biol Chem (2006) 1.00
Calcium ions promote formation of amyloid β-peptide (1-40) oligomers causally implicated in neuronal toxicity of Alzheimer's disease. PLoS One (2011) 1.00
The antibiotic and DNA-transfecting peptide LAH4 selectively associates with, and disorders, anionic lipids in mixed membranes. FASEB J (2005) 0.99
Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy. J Gene Med (2002) 0.99
Zwitterionic phospholipids and sterols modulate antimicrobial peptide-induced membrane destabilization. Biophys J (2007) 0.99
Humoral and cellular capsid-specific immune responses to adeno-associated virus type 1 in randomized healthy donors. J Immunol (2012) 0.98
Efficient gene targeting mediated by a lentiviral vector-associated meganuclease. Nucleic Acids Res (2011) 0.98
Quantitative proteomic analysis of lentiviral vectors using 2-DE. Proteomics (2009) 0.98
Lipid-controlled peptide topology and interactions in bilayers: structural insights into the synergistic enhancement of the antimicrobial activities of PGLa and magainin 2. Biophys J (2011) 0.98
Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferase. J Biol Chem (2002) 0.98
Structure and alignment of the membrane-associated peptaibols ampullosporin A and alamethicin by oriented 15N and 31P solid-state NMR spectroscopy. Biophys J (2009) 0.97
Solid-state NMR spectroscopy of oriented membrane polypeptides at 100 K with signal enhancement by dynamic nuclear polarization. J Am Chem Soc (2010) 0.97
RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cells. J Immunol (2003) 0.97
Comparative analysis of the CD8(+) T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice. Int Immunol (2002) 0.96
Macromolecular crowding at membrane interfaces: adsorption and alignment of membrane peptides. J Mol Biol (2007) 0.96
Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity. Blood (2005) 0.95
Intranasal gene delivery with a polyethylenimine-PEG conjugate. J Control Release (2002) 0.95
Magainin 2 in phospholipid bilayers: peptide orientation and lipid chain ordering studied by X-ray diffraction. Biochim Biophys Acta (2002) 0.95
Deciphering membrane insertion of the diphtheria toxin T domain by specular neutron reflectometry and solid-state NMR spectroscopy. J Mol Biol (2009) 0.95
A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells. Mol Ther (2005) 0.95
Self-promoted cellular uptake of peptide/DNA transfection complexes. Biochemistry (2007) 0.94
Membrane interactions of the amphipathic amino terminus of huntingtin. Biochemistry (2013) 0.93
The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells. J Biol Chem (2003) 0.93
Optimising histidine rich peptides for efficient DNA delivery in the presence of serum. J Control Release (2006) 0.93
Enhanced membrane disruption and antibiotic action against pathogenic bacteria by designed histidine-rich peptides at acidic pH. Antimicrob Agents Chemother (2006) 0.92
Membrane order perturbation in the presence of antimicrobial peptides by (2)H solid-state NMR spectroscopy. Biochimie (2009) 0.92
Crystal structure and functional mechanism of a human antimicrobial membrane channel. Proc Natl Acad Sci U S A (2013) 0.91
A spectroscopic study of the membrane interaction of the antimicrobial peptide Pleurocidin. Mol Membr Biol (2006) 0.91
Structure and membrane interactions of the antibiotic peptide dermadistinctin K by multidimensional solution and oriented 15N and 31P solid-state NMR spectroscopy. Biophys J (2009) 0.91
Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation. Hum Mol Genet (2008) 0.90
Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiency. Blood (2002) 0.90
Femoral intra-arterial injection: a tool to deliver and assess recombinant AAV constructs in rodents whole hind limb. J Gene Med (2005) 0.90
Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockade. Hum Gene Ther (2015) 0.90
Tilt and rotational pitch angle of membrane-inserted polypeptides from combined 15N and 2H solid-state NMR spectroscopy. Biochemistry (2004) 0.89
Global transcriptional characterization of SP and MP cells from the myogenic C2C12 cell line: effect of FGF6. Physiol Genomics (2005) 0.89
Interactions involved in the realignment of membrane-associated helices. An investigation using oriented solid-state NMR and attenuated total reflection Fourier transform infrared spectroscopies. J Biol Chem (2006) 0.89
Solid-state NMR investigations of membrane-associated antimicrobial peptides. Methods Mol Biol (2010) 0.88
Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis. Hum Gene Ther (2002) 0.88
Aggregation and membrane permeabilizing properties of designed histidine-containing cationic linear peptide antibiotics. J Pept Sci (2008) 0.88
Membrane structure and conformational changes of the antibiotic heterodimeric peptide distinctin by solid-state NMR spectroscopy. Proc Natl Acad Sci U S A (2009) 0.88
Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott-Aldrich syndrome. J Gene Med (2009) 0.88
Characterization of the gene transfer process mediated by histidine-rich peptides. J Mol Med (Berl) (2006) 0.87
Cationic steroid antibiotics demonstrate DNA delivery properties. J Control Release (2005) 0.87
A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation. J Biol Chem (2002) 0.86
Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity. J Virol (2013) 0.86
Dilution of reporter gene with stuffer DNA does not alter the transfection efficiency of polyethylenimines. J Gene Med (2005) 0.86
Bilayer sample for fast or slow magic angle oriented sample spinning solid-state NMR spectroscopy. J Am Chem Soc (2002) 0.86
Assessment of optimal transduction of primary human skin keratinocytes by viral vectors. J Gene Med (2005) 0.86
Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A. Mol Ther (2005) 0.85
Membrane structure and interactions of human catestatin by multidimensional solution and solid-state NMR spectroscopy. FASEB J (2010) 0.85
Safe selection of genetically manipulated human primary keratinocytes with very high growth potential using CD24. Mol Ther (2007) 0.85
Solid-state NMR approaches to measure topological equilibria and dynamics of membrane polypeptides. Biochim Biophys Acta (2009) 0.85
Translocation of amino acyl residues from the membrane interface to the hydrophobic core: thermodynamic model and experimental analysis using ATR-FTIR spectroscopy. Mol Membr Biol (2006) 0.84
Antigen-specific Treg impair CD8(+) T-cell priming by blocking early T-cell expansion. Eur J Immunol (2010) 0.84
Alamethicin topology in phospholipid membranes by oriented solid-state NMR and EPR spectroscopies: a comparison. J Phys Chem B (2009) 0.84
Gene expression profiling to monitor therapeutic and adverse effects of antisense therapies for Duchenne muscular dystrophy. Pharmacogenomics (2006) 0.84
The compartmentalisation of phosphorylated free oligosaccharides in cells from a CDG Ig patient reveals a novel ER-to-cytosol translocation process. PLoS One (2010) 0.84
Neurotropism and retrograde axonal transport of a canine adenoviral vector: a tool for targeting key structures undergoing neurodegenerative processes. Mol Ther (2002) 0.84
NMR structures of the histidine-rich peptide LAH4 in micellar environments: membrane insertion, pH-dependent mode of antimicrobial action, and DNA transfection. Biophys J (2010) 0.84
Side chain resonances in static oriented proton-decoupled 15N solid-state NMR spectra of membrane proteins. J Am Chem Soc (2009) 0.83
Rescue of a dystrophin-like protein by exon skipping in vivo restores GABAA-receptor clustering in the hippocampus of the mdx mouse. Mol Ther (2010) 0.83